Medicare Enrolled
Dr. Stephen Kimmel, M.D.
Family Medicine · Asheboro, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kimmel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kimmel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kimmel
Dr. Stephen Kimmel is a family medicine specialist in Asheboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kimmel performed 4,398 Medicare services across 1,959 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kimmel received a total of $11,792 from 47 pharmaceutical and/or device companies across 665 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kimmel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in NC
$11,792 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,398
Medicare services
Top 4% in NC for family medicine
1,959
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~220 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,310 | $5 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
430 | $53 | $90 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
414 | $35 | $90 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
312 | $34 | $65 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
253 | $49 | $130 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
143 | $76 | $125 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
134 | $55 | $135 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
114 | $105 | $345 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
76 | $62 | $115 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $9 | $30 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
35 | $37 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $86 | $128 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
20 | $121 | $200 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
17 | $144 | $305 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
15 | $321 | $545 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
15 | $30 | $80 |
| Destruction of skin growth, 15 or more growths | 14 | $89 | $200 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
13 | $137 | $250 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
12 | $87 | $325 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 12 | $106 | $270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,792
Total received (2018-2024)
Avg $1,685/year across 7 years
Top 3% in NC for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
665
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,792 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,434
2023
$2,257
2022
$1,963
2021
$1,290
2020
$1,090
2019
$1,292
2018
$1,466
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$332
UCB, Inc.
$308
E.R. Squibb & Sons, L.L.C.
$258
Janssen Biotech, Inc.
$217
Amgen Inc.
$207
Novartis Pharmaceuticals Corporation
$181
GENZYME CORPORATION
$154
SUN PHARMACEUTICAL INDUSTRIES INC.
$109
Dermavant Sciences, Inc.
$94
Incyte Corporation
$92
LEO Pharma Inc.
$68
Kerecis Limited
$60
PFIZER INC.
$58
Tactile Systems Technology Inc
$54
Regeneron Healthcare Solutions, Inc.
$46
Lilly USA, LLC
$46
Ortho Dermatologics, a division of Bausch Health US, LLC
$45
Arcutis Biotherapeutics, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Organogenesis Inc.
$19
Galderma Laboratories, L.P.
$17
Organon Llc
$14
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,102
Novartis Pharmaceuticals Corporation
$1,095
Janssen Biotech, Inc.
$1,055
GENZYME CORPORATION
$880
Regeneron Healthcare Solutions, Inc.
$704
Sun Pharmaceutical Industries Inc.
$682
Amgen Inc.
$656
UCB, Inc.
$599
E.R. Squibb & Sons, L.L.C.
$563
Lilly USA, LLC
$563
AbbVie Inc.
$558
PFIZER INC.
$451
AbbVie, Inc.
$429
LEO Pharma Inc.
$331
Ortho Dermatologics, a division of Bausch Health US, LLC
$304
Incyte Corporation
$274
SUN PHARMACEUTICAL INDUSTRIES INC.
$185
Mayne Pharma Inc.
$157
Dermavant Sciences, Inc.
$131
Galderma Laboratories, L.P.
$112
Kerecis Limited
$101
Arcutis Biotherapeutics, Inc.
$89
Promius Pharma LLC
$63
Almirall LLC
$54
Tactile Systems Technology Inc
$54
PruGen, Inc. Pharmaceuticals
$53
NOVARTIS PHARMACEUTICALS CORPORATION
$46
Genentech USA, Inc.
$46
Celgene Corporation
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Hill Dermaceuticals, Inc.
$40
EPI Health, LLC
$39
ORGANOGENESIS INC.
$30
DERMIRA, INC.
$27
VYNE Pharmaceuticals Inc.
$26
Smith+Nephew, Inc.
$26
Journey Medical Corporation
$25
MAYNE PHARMA INC.
$23
Organogenesis Inc.
$19
Taro Pharmaceuticals USA, Inc.
$18
Biofrontera Inc.
$17
Nabriva Therapeutics, plc
$15
Organon Llc
$14
Kowa Pharmaceuticals America, Inc.
$13
Mission Pharmacal Company
$13
Mylan Pharmaceuticals Inc.
$11
Gebauer Company
$11
Top 3 companies account for 27.6% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · BLU-U · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DermOtic · ELIDEL · ENSTILAR · EPSOLAY · EUCRISA · Enbrel · Erivedge · Flexitouch Plus · GRAFIX PL · HADLIMA · HALOG (Halcinonide Cream · HUMIRA · Humira · ILUMYA · Ilumya · JUBLIA · Kerecis Omega3 SurgiClose · LEVULAN KERASTICK · LIBTAYO · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Otezla · Ovace · Puraply · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOLODYN · SOOLANTRA · STRAVIX · Seglentis · Sernivo · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · TargaDox · Tremfya · Trianex · USP) 0.1% · VTAMA · Xolair · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in NC.
Geographic Context
Family medicine physicians within 10 mi
238
Per 100K population
163.8
County median income
$59,047
Nearest hospital
RANDOLPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kimmel is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NC), with low-engagement industry engagement in the top 3% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kimmel experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Kimmel performed 2,310 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kimmel receive payments from pharmaceutical companies?
Yes. Dr. Kimmel received a total of $11,792 from 47 companies across 665 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kimmel's costs compare to other family medicine physicians in Asheboro?
Dr. Kimmel's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kimmel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Asheboro
Browse family medicine physicians in Asheboro ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NC
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NC
Which NC family medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology